THBS2 and lung carcinoma: Markedly over-expression of THBS2 and its co-expressed genes (such as VCAN, CLO11A1, FAP) predicts poor survival of patients with lung cancer; down-regulation of VCAN and THBS2 inhibits cell proliferation in NSCLC [22].